Growth Equity

A landmark donation accelerates NUNM's campus growth, promising a new integrative medicine center to meet the soaring demand for holistic healthcare.

Ex-Intel leader Will Ferrier joins 3Strands Global Foundation as COO, aiming to amplify the non-profit's tech-driven prevention and survivor support.

Sterling Investment Partners hires Noah Bishop as SVP, a strategic move to bolster its deal-making and value creation in a competitive middle-market landscape.

Onramper integrates Payward Ramp, giving its partners access to Kraken's deep liquidity and compliance engine, drastically simplifying fiat-to-crypto payments.

Former USAA CEO Wayne Peacock joins Cotality's board, signaling a strategic push to lead the AI-driven property data and insurance analytics market.

A new partnership aims to capitalize on surging defense spending and supply chain shifts, signaling a new era for specialized private equity investing.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

Struggling biotech Jupiter Neurosciences presents its Parkinson's drug to elite investors at Mar-a-Lago, betting its hybrid business model can win funding.

With a new CEO at the helm and a pivotal trial for its lead drug on the horizon, all eyes are on PureTech's upcoming investor conference presentation.

A new national research initiative will explore how AI can help universities scale online programs without sacrificing quality, focusing on human-AI collaboration.

Cutting Horse, led by operators behind billion-dollar brands, exceeds its target to deploy capital and hands-on expertise to founder-led businesses.

As AI agents and non-human identities multiply, Hush Security's new platform aims to replace risky static secrets with unified, identity-based access.

Fastest-growing US professional skincare brand HYDRINITY partners with VeraSeaCosmetics, bringing its regenerative science to France's $5.4B beauty scene.

Fort Worth Plastic Surgery's new partnership with a PE-backed group highlights a major industry shift, raising questions about growth, autonomy, and patient care.

Cell and gene therapy manufacturer OXB posts a dramatic turnaround to profitability, with surging revenues and an ambitious forecast for the coming years.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

Cybersecurity leader KnowBe4 appoints Yuneeb Khan as CFO, signaling a strategic focus on scaling its AI-driven human risk management platform.

Kurv's new KCOP ETF offers investors a unique way to play the copper market, combining mining exposure with an options strategy for enhanced income.

With a new $50M facility from CIBC, Montreal-based AlayaCare is poised to accelerate its M&A strategy and advance its mission to digitize home care.

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.